Teva unveils Alyq, its generic AdcircaTeva's generic of Eli Lilly's Adcirca is indicated to treat pulmonary arterial hypertension. J&J to include cost information in TV drug adsJanssen will include both the list price and potential patient out-of-pocket costs in future direct-to-consumer TV ads. CSS Health to offer medication adherence, compliance solutions CSS Health, Medicine-on-Time, and Clinical Support Services are joining together to offer medication therapy management solutions. Upsher-Smith, NASPA honor 40 pharmacists Forty pharmacists are being honored as 2018 NASPA Excellence in Innovation Award recipients. Cardinal Health posts 7% growth in Q2 Cardinal Health's second-quarter results saw growth being led by the company’s pharmaceutical segment. FDA approves Lupin’s generic Adcirca The Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018. Ablynx gets FDA green light for Cablivi Ablynx's Cablivi is the first therapy for the treatment of adult patients with a rare blood clotting disorder. APhA revises guidelines on pharmacy-based immunizations The APhA has revised its immunization guidelines for pharmacies — marking the second time they have been updated since their adoption in 1997. Camber launches generic Adcirca Camber's generic Adcirca is indicated to treat pulmonary arterial hypertension. Amplicare expands tech offerings for pharmacists Amplicare’s latest updates are aimed at arming pharmacists with solutions to address the opioid epidemic and flu season, the company said. First Previous 537 538 539 540 541 Next Last
